XML 31 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net income $ 4,867 $ 5,246
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 21,647 30,095
Provision for doubtful accounts and sales returns 788 305
Stock-based compensation expense 22,170 33,570
Deferred taxes (221) (12,239)
Amortization of deferred financing costs and discount 699 349
Loss on disposition of businesses 0 1,561
Other non-cash adjustments (5,384) 0
Changes in operating assets and liabilities, net of acquisition and disposal of businesses:    
Accounts receivable 4,770 3,844
Prepaid expenses and other assets (5,330) (3,265)
Trade accounts payable (4,651) 23,086
Accrued expenses and other liabilities (8,207) 7,912
Deferred revenue (29,760) (25,845)
Net cash provided by operating activities 1,388 64,619
Cash flows from investing activities    
Purchase of property and equipment (688) (261)
Capitalized software development costs (12,970) (13,070)
Cash used in disposition of business (12,235) (1,179)
Net cash used in investing activities (25,893) (14,510)
Cash flows from financing activities    
Proceeds from issuance of debt 216,200 339,800
Payments on debt (85,523) (79,343)
Employee taxes paid for withheld shares upon equity award settlement (37,948) (52,723)
Change in due to customers (320,248) (336,578)
Change in customer funds receivable (2,483) (3,197)
Purchase of treasury stock (100,030) (262,596)
Net cash used in financing activities (330,032) (394,637)
Effect of exchange rate on cash, cash equivalents and restricted cash 1,668 (860)
Net decrease in cash, cash equivalents and restricted cash (352,869) (345,388)
Cash, cash equivalents and restricted cash, beginning of period 809,512 728,257
Cash, cash equivalents and restricted cash, end of period 456,643 $ 382,869
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 37,243  
Total restricted cash 419,400  
Total cash, cash equivalents and restricted cash in the statement of cash flows $ 456,643